Trials / Withdrawn
WithdrawnNCT02562417
Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Centre Hospitalier Universitaire Vaudois · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Sugammadex is used as a reversal drug for rocuronium- or vecuronium-induced neuromuscular block during general anaesthesia. IV dexamethasone is injected as a prophylactic measure against postoperative nausea and vomiting. Recent animal data have shown that dexamethasone may impair the reversal effect of sugammadex. The objective of this randomised controlled trial is to confirm in the clinical practice these preliminary results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Normal saline | |
| DRUG | IV dexamethasone |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2015-09-29
- Last updated
- 2017-07-21
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02562417. Inclusion in this directory is not an endorsement.